Steven Pieper
Direttore Finanziario/CFO presso XERIS BIOPHARMA HOLDINGS, INC.
Patrimonio netto: 872 922 $ in data 31/05/2024
Profilo
Steven M.
Pieper is currently the Chief Financial Officer at Xeris Biopharma Holdings, Inc. He previously worked as the Finance Director at Durata Therapeutics, Inc. and as the Chief Financial & Accounting Officer at Xeris Pharmaceuticals, Inc. He also served as the Chief Operating & Financial Officer at Catheter Connections, Inc. from 2015 to 2017.
Mr. Pieper obtained his undergraduate degree from DePaul University and holds an MBA from Loyola University of Chicago.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
| 12/04/2024 | 387 105 ( 0.26% ) | 872 922 $ | 31/05/2024 |
Posizioni attive di Steven Pieper
| Società | Posizione | Inizio |
|---|---|---|
| XERIS BIOPHARMA HOLDINGS, INC. | Direttore Finanziario/CFO | 01/10/2021 |
Precedenti posizioni note di Steven Pieper
| Società | Posizione | Fine |
|---|---|---|
Catheter Connections, Inc.
 Catheter Connections, Inc. Medical SpecialtiesHealth Technology Catheter Connections, Inc. develops vascular access products. Its flagship product DualCap, designed to protect patients from acquiring infections during intravenous infusion therapy. It disinfects both IV tubing end connectors and needle-free valves. The company was founded by Michael W. Howlett, James Mercer, Vicki Farrar, and Robert Hitchcock in 2008 and is headquartered in Salt Lake City, Utah. | Direttore Finanziario/CFO | 01/01/2017 |
| DURATA THERAPEUTICS INC | Direttore Finanziario/CFO | - |
Xeris Pharmaceuticals, Inc.
 Xeris Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Xeris Pharmaceuticals, Inc. operates as a pharmaceutical company. It develops and commercializes ready-to-use, liquid-stable injectables. The firm offers XeriSol and XeriJect formulation technologies. Its products include Gvoke Pre-Filled Syringe and Gvoke HypoPen. The company was founded by Steven Prestrelski and John Kinzell in 2005 and is headquartered in Chicago, IL. | Direttore Finanziario/CFO | - |
Formazione di Steven Pieper
| DePaul University | Undergraduate Degree |
| Loyola University of Chicago | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| XERIS BIOPHARMA HOLDINGS, INC. | Health Technology |
| Aziende private | 3 |
|---|---|
Xeris Pharmaceuticals, Inc.
Xeris Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Xeris Pharmaceuticals, Inc. operates as a pharmaceutical company. It develops and commercializes ready-to-use, liquid-stable injectables. The firm offers XeriSol and XeriJect formulation technologies. Its products include Gvoke Pre-Filled Syringe and Gvoke HypoPen. The company was founded by Steven Prestrelski and John Kinzell in 2005 and is headquartered in Chicago, IL. | Health Technology |
Catheter Connections, Inc.
Catheter Connections, Inc. Medical SpecialtiesHealth Technology Catheter Connections, Inc. develops vascular access products. Its flagship product DualCap, designed to protect patients from acquiring infections during intravenous infusion therapy. It disinfects both IV tubing end connectors and needle-free valves. The company was founded by Michael W. Howlett, James Mercer, Vicki Farrar, and Robert Hitchcock in 2008 and is headquartered in Salt Lake City, Utah. | Health Technology |
Durata Therapeutics, Inc.
 Durata Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Durata Therapeutics, Inc. develops and commercializes novel therapeutics for infectious diseases and acute illnesses. The company was founded on November 4, 2009 and is headquartered in Chicago, IL. | Health Technology |
- Borsa valori
- Insiders
- Steven Pieper
